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color Doppler suggests the existence of the rostrum. The patient was carefully monitored after 
the surgery. 24 days after the surgery the general status of the patient becomes altered, the patient 
presenting jet vomiting and nystagmus. The transfontanellar ultrasound showed 
ventriculomegaly with intracranial pressure (IR: 0.79->0.95) and the lumbar puncture showed 
transparent, sterile cerebrospinal fluid for which she remains carefully monitored.  
Conclusions. Although rare, agenesis of the corpus callosum is easely recognisable on CT scan 
and neonatal ultrasound. Even it is itself asymptomatic, may be associated with other 
malformations, especially in genetic syndromes, playing an important role in the production of 
neurological symptoms. 
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Background. Atypical chronic myeloid leukemia (aCML), BCR-ABL1 negative is a rare 
myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) for which no current 
standard of care exists. ACML is characterized by many clinical features (splenomegaly, myeloid 
predominance in the bone marrow with some dysplastic features but without a differentiation 
block) and laboratory abnormalities (myeloid proliferation, low leukocyte alkaline phosphate 
values). A review of the literature suggests that the presence of an abnormal chromosome 21 may 
predispose to the development of leukemia.  
Case report. A 41-year-old man with a past medical history of Down syndrome (47, XY, +21) 
was admitted to the Haematology Unit of Mures Country Emergency Hospital with severe 
anemia, thrombocytopenia and leukocytosis. Following the peripheral smear, bone marrow 
biopsy and RT-PCR for bcr/abl (negative) indicated atypical chronic myeloid leukemia or 
myelodysplastic syndrome(MDS)/myeloproliferative neoplasm(MPN) grade III. The substitution 
treatment was established and the condition of the patient has evolved unfavorably with 
bronchopneumonia, respiratory failure, diffuse micropapous rash and Clostridium colitis. Due to 
chromosomal abnormality the cytostatic treatment is difficult to administer. The RT-PCR for 
JAK2, cMPL, CALR was negative. The final diagnosis falls as a myeloid neoplasia associated 
with Down syndrome with blasts lower than 20% at the medullary level, but in terms of WHO 
classification, the blastic percentage is not relevant. Therefore, the treatment chosen was mild 
cytoreduction (ARA-C) and substitution depending on tolerance, but even with the correctly 
administered treatment the patient died after ten months. 
Conclusions. In conclusion, atypical chronic myeloid leukemia is a rare disease and the 
association with chromosomal abnormalities and the lack of standards of care is a challenge in 
treating these patients and poor results should be expected.  
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